Higher striatal dopamine transporters in euthymic patients with bipolar disorder: A SPECT study with [99mTc] TRODAT-1

Bipolar Disorders

Volumn 12, Issue 1, 2010, Pages 102-106

  Chang, Ting Ting ^a,b,c   Yeh, Tzung Lieh ^a   Chiu, Nan Tsing ^b   Chen, Po See ^a   Huang, Hsiang Yu ^b   Yang, Yen Kuang ^a   Lee, I Hui ^a   Lu, Ru Band ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

Author keywords

Bipolar disorder; Dopamine transporter availability; Euthymic state; SPECT

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; DOPAMINE TRANSPORTER;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BIPOLAR DISORDER; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES; YOUNG ADULT;

EID: 75249104675     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2009.00771.x     Document Type: Article

References (31)

1. Berk M, Dodd S, Kauer-Sant'anna M. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl 2007, 434:41-49.
2. Delgado PL. Depression: the case for a monoamine deficiency. J Clin Psychiatry 2000, 61(Suppl. 6):7-11.
3. Diehl DJ, Gershon S. The role of dopamine in mood disorders. Compr Psychiatry 1992, 33:115-120.
4. Zarate CA, Payne JL, Singh J. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry 2004, 56:54-60.
5. Jaber M, Jones S, Giros B, Caron MG. The dopamine transporter: a crucial component regulating dopamine transmission. Mov Disord 1997, 12:629-633.
6. Madras BK, Miller GM, Fischman AJ. The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). Behav Brain Res 2002, 130:57-63.
7. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379:606-612.
8. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 1998, 95:4029-4034.
9. Horschitz S, Hummerich R, Lau T, Rietschel M, Schloss P. A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression. Mol Psychiatry 2005, 10:1104-1109.
10. Mick E, Kim JW, Biederman J. Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1182-1185.
11. Wessa M, Houenou J, Paillere-Martinot ML. Fronto-striatal overactivation in euthymic bipolar patients during an emotional go/nogo task. Am J Psychiatry 2007, 164:638-646.
12. Strakowski SM, Adler CM, Holland SK, Mills NP, DelBello MP, Eliassen JC. Abnormal fMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task. Am J Psychiatry 2005, 162:1697-1705.
13. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA 2005, 293:2528-2530.
14. Swann AC. What is bipolar disorder? Am J Psychiatry 2006, 163:177-179.
15. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978, 35:837-844.
16. Merikangas KR, Stevens DE, Fenton B. Comorbidity and familial aggregation of alcoholism and anxiety disorders. Psychol Med 1998, 28:773-788.
17. Strakowski SM, Adler CM, Holland SK, Mills N, DelBello MP. A preliminary fMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacology 2004, 29:1734-1740.
18. Sheehan DV, Lecrubier Y, Sheehan KH. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59:22-33.
19. Hwang WJ, Yao WJ, Wey SP, Ting G. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. J Nucl Med 2004, 45:207-213.
20. Chen PS, Yang YK, Yeh TL. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers-a SPECT study. Neuroimage 2008, 40:275-279.
21. Zubieta JK, Taylor SF, Huguelet P, Koeppe RA, Kilbourn MR, Frey KA. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biol Psychiatry 2001, 49:110-116.
22. Henry JP, Scherman D. Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles. Biochem Pharmacol 1989, 38:2395-2404.
23. Fon EA, Pothos EN, Sun BC, Killeen N, Sulzer D, Edwards RH. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 1997, 19:1271-1283.
24. Lu W, Wolf ME. Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration. Mol Brain Res 1997, 49:137-148.
25. Vander Borght TM, Sima AAF, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA. [3H]Methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity. Neuroscience 1995, 68:955-962.
26. Yatham LN. Atypical antipsychotics for bipolar disorder. Psychiatr Clin North Am 2005, 28:325-347.
27. Minton GO, Young AH, McQuade R, Fairchild G, Ingram CD, Gartside SE. Profound changes in dopaminergic neurotransmission in the prefrontal cortex in responses to flattening of the diurnal glucocorticoid rhythm: implications for bipolar disorder. Neuropsychopharmacology 2009, 53:1-10.
28. Yatham LN, Liddle PF, Lam RW. PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania. Am J Psychiatry 2002, 159:1718-1723.
29. Yatham LN, Liddle PF, Shiah IS. PET study of [(18)F]6-fluoro-l-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium. Am J Psychiatry 2002, 159:768-774.
30. Yatham LN, Malhi GS. Neurochemical brain imaging studies in bipolar disorder. Acta Neuropsychiatrica 2003, 15:381-387.
31. Anand A, Verhoeff P, Seneca N. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 2000, 157:1108-1114.